Protein kinase C isozymes ε and α in murine erythroleukemia cells

C. T. Powell, L. Leng, L. Dong, H. Kiyokawa, X. Busquets, K. O'Driscoll, P. A. Marks, R. A. Rifkind

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Protein kinase C (PKC) has a role in signal transduction during hexamethylene bisacetamide (HMBA)-induced differentiation of murine erythroleukemia cells (MELC). Separation of MELC PKC isozymes by hydroxylapatite chromatography yields a major peak (III) and a minor peak (II) of PKC activity, previously reported to contain the PKC α and β isozymes, respectively. In the present study, we confirm that peak III activity is PKCα but show that peak II contains PKCε and little or no PKCβ. Immunoblot analysis with isozyme-specific anti-α and anti-ε PKC antibodies detected PKCα in peak III and PKCε in peak II. Peak III activity was markedly enhanced (up to 20-fold) by phosphatidylserine, diolein, and Ca2+, whereas addition of these cofactors to the reaction mixture stimulated peak II activity only 2- to 4-fold. RNase protection analysis of MELC RNA showed that PKCα and PKCε RNAs were in a ratio of ≃2:1, but PKCβ RNA was barely detectable. Taken together, these data indicate that MELC contain PKCα and PKCε but little or no PKCβ.

Original languageEnglish (US)
Pages (from-to)147-151
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number1
StatePublished - 1992

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Protein kinase C isozymes ε and α in murine erythroleukemia cells'. Together they form a unique fingerprint.

Cite this